Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
ArticleAbstract: The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health EnglaPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Amato R., Ariani C.V., Ash A., Barrett J.C., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Bird P.W., Bonsall D., Boswell T., Boyd O., Bresner C., Campbell S., Chand M., Charalampous T., Clark G., Cogger B.J., Connor T.R., Cortes N., Curran T., Dabrera G., Edgeworth J., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gaythorpe K., Geidelberg L., Golubchik T., Goncalves S., Groves N., Guest M., Gulliver H., Harrison I., Hassan-Ibrahim M.O., Helmer T., Hill V., Hinsley W.R., Holmes C., Howson-Wells H.C., Jackson B., Jackson D.K., John M., Johnson R., Jones C., Jorgensen D., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Kwiatkowski D.P., Laydon D.J., Lister M.M., Loman N.J., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McCrone J.T., McKenna J.P., Menegazzo M., Merrick I., Mishra S., Moore N., Morgan S., Mori M., Munn R., Myers R., Nebbia G., O’toole A., Patel A., Price A., Ragonnet-Cronin M., Raviprakash V., Reynolds N., Robson S.C., Sheriff N., Sillitoe J., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Underwood A.P., Volz E.M., Wantoch M., Warne B., Willingham I., Wise E.L., Workman T., Yeats C.A.Fuentes:scopusImmunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
ArticleAbstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in thePalabras claves:antibody, B cell, BNT162b2, covid-19, dosing interval, Neutralization, SARS-COV-2, T cell, Vaccine, variants of concernAutores:Abuelgasim H., Adele S., Adland E., Adlou S., Akther H.D., Al-Taei S., Alhussni A., Ali M., Altmann T., Amini A., Angyal A., Arancibia-Cárcamo C.V., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Bridges-Webb A., Brown A., Brown H., Brown R., Carroll M.W., Chalk J., Chand M., Chawla A., Chinnakannan S., Conlon C.P., Cross A., Cutteridge J., de Lara C., de Silva T.I., Deeks A.S., Dejnirattisai W., Denly L., Diffey B., Dimitriadis S., Dobson S.L., Dold C., Donnison T., Drake T.M., Dunachie S.J., Duncan C.J.A., Dupont M., Eyre D.W., Fairman A., Faustini S., Foulkes S., Frater J., Gardiner S., Gillson N., Goulder P., Hackstein C.P., Hall V., Hambleton S., Haniffa M., Hargreaves A., Haworth J., Hering L.M., Holmes J., Hopkins S., Horner E., Hornsby H., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Johnson S.A., Jones C., Kasanyinga M., Kelly S., Kilby J.A., Kirk R., Klenerman P., Knight M.L., Lawrie A., Lee L., Linder A., Longet S., Malone T., Matthews P.C., Meardon N., Mongkolsapaya J., Moore S.C., Nicols A.R., Payne R.P., Phillips E., Pollard A.J., Reyes L.S., Richter A., Rowland-Jones S.L., Saei A., Sandhar G., Screaton G.R., Shields A., Skelly D.T., Stafford L., Supasa P., Tipton T., Turtle L., Tyerman J.K., Whitham R., Wootton D.G.Fuentes:scopusRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
ArticleAbstract: We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple inPalabras claves:Alpha variant, antibody escape, B.1.1.7, covid-19, deletion, infectivity, neutralizing antibodies, RESISTANCE, SARS-COV-2, spike mutationAutores:Aanensen D.M., Aggarwal D., Alderton A., Amato R., Andersson M.I., Ariani C.V., Awan A.R., Barrett J., Bashton M., Bassett A.R., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Chand M., Chapman M.H.S., Chauhan A.J., Collier D.A., Connor T.R., Constantinidou C., Corden S., Cottrell S., Curran M.D., Darby A.C., Datir R.P., de Silva T.I., Dewar R., Elliott S., Fairley D.J., Ferreira I.A.T.M., Gallo G., Glaysher S., Golubchik T., Goncalves S., Hamilton W.L., Harrison E.M., Harvey W.T., Hassan-Ibrahim M.O., Hiscox J.A., Holden M.T.G., Jackson D.K., Jahun A.S., Jesudason N.G., Johnston I., Kemp S.A., Kwiatkowski D.P., Langford C.F., Lawniczak M., Li K.K., Livett R., Loman N.J., Loose M.W., Loveson K.F., Lowe H., Ludden C., Lytras S., Marelli S., Martincorena I., Martinez Nunez R.T., McCann C.M., McHugh M.P., McKenna J.P., McMurray C., Meng B., Mlcochova P., Mohamed A., Moore C., Moses S., Nelson A., Nicholls S.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Pandey S., Papa G., Parker M.D., Parmar S., Paterson S., Prieto J.A., Pybus O.G., Rambaut A., Robson S.C., Saeed K., Shah R.N., Shepherd J.G., Sillitoe J., Smith C.P., Smith D.L., Snell L.B., Taha Y., Templeton K.E., Thakur N., Thomson E.C., Torok M.E., Underwood A.P., Unnikrishnan M., Volz E.M., Wang D., Watkins J., Young G.R.Fuentes:scopusSARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
ArticleAbstract: Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in tPalabras claves:covid-19, Delta variant, GENETIC DIVERSITY, mutation, SARS-COV-2, Transmission advantageAutores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Atchison C., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bodinier B., Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Chand M., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., Darby A.C., De Angelis D., de Oliveira Martins L., de Silva T.I., Eales O., Eastick K., Fairley D.J., Frampton D., Glaysher S., Golubchik T., Goncalves S., Goodfellow I.G., Gunson R.N., Gupta R.K., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Haw D., Holden M.T.G., Houlihan C., Jackson D.K., Jackson L.M., Johnston I., Jonnerby J., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nunez R.T.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Parker M.D., Parmar S., Paterson S., Pope C.F., Prieto J.A., Pybus O.G., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Snell L.B., Templeton K.E., Thomas C., Thomson E.C., Torok M.E., Underwood A.P., Volz E.M., Wang D., Wang H., Watkins J., Williams C., Witney A.A.Fuentes:scopusT-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
ArticleAbstract: Background: Previous infection with SARS-CoV-2 affects the immune response to the first dose of thePalabras claves:Autores:Abuelgasim H., Adland E., Adlou S., Alhussni A., Ali M., Angyal A., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Brown A., Brown H., Brown R., Carroll M.W., Chand M., Chawla A., Conlon C.P., Cross A., Cutteridge J., de Silva T.I., Deeks A.S., Denly L., Diffey B., Dobson S.L., Dold C., Dunachie S.J., Duncan C.J.A., Fairman A., Frater J., Gardiner S., Gillson N., Goulder P., Hall V., Harding A.C., Harrington K., Haworth J., Hering L.M., Holmes J., Hopkins S., Hornsby H., James W.S., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Jones C., Kasanyinga M., Kilby J.A., Kirk R., Klenerman P., Lawrie A., Lett L., Lillie K., Longet S., Marsh L., Matthews P., Matthews P.C., Meardon N., Mehta H., Moore S.C., Nicols A.R., O'Donnell D., Ogbe A., Pace M., Payne R.P., Platt G., Richter A., Romaniuk L., Rongkard P., Rowland-Jones S.L., Sandhar G., Shields A., Skelly D.T., Smith N., Spegarova J.S., Subramaniam K., Thomas S.R., Tipton T., Tucker S., Turtle L., Turton H., Tyerman J.K., Watson A.J.R., Watson L., Webb-Bridges A., Weeks E., Whitham R., Wilson R., Wood S., Xiao H., Zawia A.Fuentes:scopus